Formation and development of Lewy pathology: A critical update

Journal of Neurology

Volumn 256, Issue SUPPL. 3, 2009, Pages

  Jellinger, Kurt A ^a  

^a INSTITUTE OF CLINICAL NEUROBIOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE; DOPAMINE TRANSPORTER; TYROSINE 3 MONOOXYGENASE;

AGED; AMINO ACID SEQUENCE; AUTONOMIC NERVOUS SYSTEM; BRAIN CORTEX; BRAIN REGION; BRAIN STEM; CELL LOSS; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CONFERENCE PAPER; COURSE EVALUATION; DEGENERATIVE DISEASE; DIFFUSE LEWY BODY DISEASE; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; HUMAN; LEWY BODY; LIMBIC SYSTEM; MEDULLA OBLONGATA; NERVE CELL; NERVE CELL NECROSIS; NEURITE; NEUROAXONAL DYSTROPHY; NONHUMAN; OLFACTORY NUCLEUS; PARKINSON DISEASE; PERIPHERAL NERVOUS SYSTEM; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; TISSUE STRUCTURE; UBIQUITINATION;

ALPHA-SYNUCLEIN; BIOLOGICAL MARKERS; BRAIN; DISEASE PROGRESSION; HUMANS; LEWY BODIES; LEWY BODY DISEASE; NEURONS; PARKINSON DISEASE;

EID: 69549116777     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5243-y     Document Type: Conference Paper

References (98)

1. L Aho L Parkkinen T Pirttila I Alafuzoff 2008 Systematic appraisal using immunohistochemistry of brain pathology in aged and demented subjects Dement Geriatr Cogn Disord 25 423 432
2. I Alafuzoff L Parkkinen S Al-Sarraj T Arzberger J Bell I Bodi N Bogdanovic H Budka I Ferrer E Gelpi S Gentleman G Giaccone W Kamphorst A King P Korkolopoulou GG Kovacs S Larionov D Meyronet C Monoranu J Morris P Parchi E Patsouris W Roggendorf D Seilhean N Streichenberger DR Thal H Kretzschmar 2008 Assessment of α-synuclein pathology: a study of the BrainNet Europe Consortium J Neuropathol Exp Neurol 67 125 143
3. Alafuzoff I, Ince PG, Arzberger T, Al-Sarraj S, Bell J, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kovacs GG, Meyronet D, Monoranu C, Parchi P, Parkkinen L, Patsouris E, Roggendorf W, Rozemuller A, Stadelmann-Nessler C, Streichenberger N, Thal DR, Kretzschmar H (2009) Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol 117:635-652
4. JP Anderson DE Walker JM Goldstein R de Laat K Banducci RJ Caccavello R Barbour J Huang K Kling M Lee L Diep PS Keim X Shen T Chataway MG Schlossmacher P Seubert D Schenk S Sinha WP Gai TJ Chilcote 2006 Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease J Biol Chem 281 29739 29752
5. J Attems KA Jellinger 2008 The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease Neuropathol Appl Neurobiol 34 466 467
6. Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J, Sasse J, Boyer S, Shirohi S, Brooks R, Eschbacher J, White CL III, Akiyama H, Caviness J, Shill HA, Connor DJ, Sabbagh MN, Walker DG (2009) Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117:613-634
7. H Bernheimer W Birkmayer O Hornykiewicz K Jellinger F Seitelberger 1973 Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations J Neurol Sci 20 415 455
8. A Bloch A Probst H Bissig H Adams M Tolnay 2006 α-Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects Neuropathol Appl Neurobiol 32 284 295
9. H Braak K Del Tredici U Rub RA de Vos EN Jansen Steur E Braak 2003 Staging of brain pathology related to sporadic Parkinson's disease Neurobiol Aging 24 197 211
10. H Braak U Rub EN Jansen Steur K Del Tredici RA de Vos 2005 Cognitive status correlates with neuropathologic stage in Parkinson disease Neurology 64 1404 1410
11. H Braak JR Bohl CM Muller U Rub RA de Vos K Del Tredici 2006 Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered Mov Disord 21 2042 2051
12. H Braak K Del Tredici 2008 Nervous system pathology in sporadic Parkinson disease Neurology 70 1916 1925
13. A Bruck S Aalto E Rauhala J Bergman R Marttila JO Rinne 2009 A follow-up study on 6-[18F]fluoro-l-dopa uptake in early Parkinson's disease shows nonlinear progression in the putamen Mov Disord 24 1009 1015
14. P Brundin JY Li JL Holton O Lindvall T Revesz 2008 Research in motion: the enigma of Parkinson's disease pathology spread Nat Rev Neurosci 9 741 745
15. RE Burke WT Dauer JPG Vonsattel 2008 The Braak staging scheme for Parkinson's disease: a reappraisal Ann Neurol 64 485 491
16. SA Burns CR Moran PL Pingerelli VV Ozols RS Burns 2008 Redefining the Lewy body: evidence of distinct protein composition and nonrandom assembly process (abstr) Mov Disord 23 Suppl 1 S22
17. P Calabresi NB Mercuri M Di Filippo 2009 Synaptic plasticity, dopamine and Parkinson's disease: one step ahead Brain 132 285 287
18. RJ Castellani HG Lee X Zhu G Perry MA Smith 2008 Alzheimer disease pathology as a host response J Neuropathol Exp Neurol 67 523 531
19. C Colosimo AJ Hughes L Kilford AJ Lees 2003 Lewy body cortical involvement may not always predict dementia in Parkinson's disease J Neurol Neurosurg Psychiatry 74 852 856
20. V Cullen M Lindfors J Ng A Paetau E Swinton P Kolodziej H Boston P Saftig J Woulfe MB Feany L Myllykangas MG Schlossmacher J Tyynela 2009 Cathepsin D expression level affects α-synuclein processing, aggregation, and toxicity in vivo Mol Brain 2 5
21. GE Dale A Probst P Luthert J Martin BH Anderton PN Leigh 1992 Relationships between Lewy bodies and pale bodies in Parkinson's disease Acta Neuropathol 83 525 529
22. A DelleDonne KJ Klos H Fujishiro Z Ahmed JE Parisi KA Josephs R Frigerio M Burnett ZK Wszolek RJ Uitti JE Ahlskog DW Dickson 2008 Incidental Lewy body disease and preclinical Parkinson disease Arch Neurol 65 1074 1080
23. DW Dickson H Fujishiro A Delledonne J Menke Z Ahmed KJ Klos KA Josephs R Frigerio M Burnett JE Parisi JE Ahlskog 2008 Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease Acta Neuropathol 115 437 444
24. JE Duda BI Giasson ME Mabon DC Miller LI Golbe VM Lee JQ Trojanowski 2002 Concurrence of α-synuclein and tau brain pathology in the Contursi kindred Acta Neuropathol 104 7 11
25. JM Fearnley AJ Lees 1994
26. LS Forno 1969 Concentric hyalin intraneuronal inclusions of Lewy type in the brains of elderly persons (50 incidental cases): relationship to parkinsonism J Am Geriatr Soc 17 557 575
27. K Fujimi K Sasaki K Noda Y Wakisaka Y Tanizaki Y Matsui A Sekita M Iida Y Kiyohara S Kanba T Iwaki 2008 Clinicopathological outline of dementia with Lewy bodies applying the revised criteria: the Hisayama study Brain Pathol 18 317 325
28. H Fujishiro TB Ahn R Frigerio H Uchikado KJ Klos KA Josephs A DelleDonne JE Parisi JE Ahlskog DW Dickson 2008 Incidental Lewy bodies in various neurodegenerative disorders (abstr.) Mov Disord 23 Suppl.1 S30
29. H Fujishiro TJ Ferman BF Boeve GE Smith NR Graff-Radford RJ Uitti ZK Wszolek DS Knopman RC Petersen JE Parisi DW Dickson 2008 Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases J Neuropathol Exp Neurol 67 649 656
30. H Fujishiro Y Tsuboi WL Lin H Uchikado DW Dickson 2008 Co-localization of tau and α-synuclein in the olfactory bulb in Alzheimer's disease with amygdala Lewy bodies Acta Neuropathol 116 269 275
31. WR Galpern AE Lang 2006 Interface between tauopathies and synucleinopathies: a tale of two proteins Ann Neurol 59 449 458
32. JE Galvin VM Lee JQ Trojanowski 2001 Synucleinopathies: clinical and pathological implications Arch Neurol 58 186 190
33. S Greffard M Verny AM Bonnet JY Beinis C Gallinari S Meaume F Piette JJ Hauw C Duyckaerts 2006 Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra Arch Neurol 63 584 588
34. Greffard S, Verny M, Bonnet AM, Seilhean D, Hauw JJ, Duyckaerts C (2008) A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death. Neurobiol Aging (online May 3, 2008)
35. G Halliday M Hely W Reid J Morris 2008 The progression of pathology in longitudinally followed patients with Parkinson's disease Acta Neuropathol 115 409 415
36. GM Halliday DA McRitchie H Cartwright R Pamphlett MA Hely JGL Morris 1996 Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease J Clin Neurosci 3 52 60
37. GM Halliday K Del Tredici H Braak 2006 Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson's disease J Neural Transm Suppl 70 99 103
38. RL Hamilton 2000 Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using α-synuclein immunohistochemistry Brain Pathol 10 378 384
39. AJ Harding GM Halliday 2001 Cortical Lewy body pathology in the diagnosis of dementia Acta Neuropathol 102 355 363
40. MA Hely WG Reid MA Adena GM Halliday JG Morris 2008 The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years Mov Disord 23 837 844
41. PG Ince B Clark J Holton T Revesz SB Wharton 2008
42. M Ishiyama S Yagishita K Hasegawa T Yokoyama 2006 Ultrastructural study (tEM and sEM) of cortical Lewy bodies Neuropathol 26 A58
43. T Ishizawa P Mattila P Davies D Wang DW Dickson 2003 Colocalization of tau and α-synuclein epitopes in Lewy bodies J Neuropathol Exp Neurol 62 389 397
44. KA Jellinger 2004 Lewy body-related α-synucleinopathy in the aged human brain J Neural Transm 111 1219 1235
45. KA Jellinger 2007
46. KA Jellinger 2007 Morphological substrates of Parkinsonism with and without dementia. A retrospective clinico-pathological study J Neural Transm Suppl 72 91 104
47. KA Jellinger 2008 A critical reappraisal of current staging of Lewy-related pathology in human brain Acta Neuropathol 116 1 16
48. KA Jellinger 2009 A critical evaluation of current staging of α-synuclein pathology in Lewy body disorder Biochim Biophys Acta 1792 730 740
49. ME Kalaitzakis MB Graeber SM Gentleman RK Pearce 2008 Controversies over the staging of α-synuclein pathology in Parkinson's disease Acta Neuropathol 116 125 128
50. ME Kalaitzakis F Roncaroli RK Pearce S Gentleman 2008 Non-stereotypical distribution of α-synuclein in the spinal cord and brain of a patient with dementia with Lewy bodies (DLB) (abstr.) Mov Disord 23 Suppl.1 S247
51. T Kanazawa TAT Uchihara A Nakamura S Orimo H Mizusawa 2008 Three-layered structure shared between Lewy bodies and Lewy neurites-three-dimensional reconstruction of triple-labeled sections Brain Pathol 18 415 422
52. O Katsuse E Iseki W Marui K Kosaka 2003 Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies J Neurol Sci 211 29 35
53. JH Kordower Y Chu RA Hauser TB Freeman CW Olanow 2008 Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease Nat Med 14 504 506
54. GG Kovacs IJ Milenkovic M Preusser H Budka 2008 Nigral burden of α-synuclein correlates with striatal dopamine deficit Mov Disord 23 1608 1612
55. E Kovari G Gold FR Herrmann A Canuto PR Hof C Bouras P Giannakopoulos 2003 Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease Acta Neuropathol 106 83 88
56. E Kuusisto L Parkkinen I Alafuzoff 2003 Morphogenesis of Lewy bodies: dissimilar incorporation of α-synuclein, ubiquitin, and p62 J Neuropathol Exp Neurol 62 1241 1253
57. HG Lee X Zhu A Takeda G Perry MA Smith 2006 Emerging evidence for the neuroprotective role of α-synuclein Exp Neurol 200 1 7
58. VM Lee BI Giasson JQ Trojanowski 2004 More than just two peas in a pod: common amyloidogenic properties of tau and α-synuclein in neurodegenerative diseases Trends Neurosci 27 129 134
59. JB Leverenz I Umar Q Wang TJ Montine PJ McMillan DW Tsuang J Jin C Pan J Shin D Zhu J Zhang 2007 Proteomic identification of novel proteins in cortical Lewy bodies Brain Pathol 17 139 145
60. JB Leverenz R Hamilton DW Tsuang A Schantz D Vavrek EB Larson WA Kukull O Lopez D Galasko E Masliah J Kaye R Woltjer C Clark JQ Trojanowski TJ Montine 2008 Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient Brain Pathol 18 220 224
61. JY Li E Englund JL Holton D Soulet P Hagell AJ Lees T Lashley NP Quinn S Rehncrona A Bjorklund H Widner T Revesz O Lindvall P Brundin 2008 Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation Nat Med 14 501 503
62. V Licker L Dayon N Turck M Côte N Rodrigo DF Hochstrasser JC Sanchez PR Burkhard 2009 Proteomic analysis of the substantia nigra in patients with Parkinson's disease (abstr.) Mov Disord 24 suppl 1 S39
63. I Litvan G Halliday M Hallett CG Goetz W Rocca C Duyckaerts Y Ben-Shlomo DW Dickson AE Lang MF Chesselet WJ Langston DA Di Monte T Gasser T Hagg J Hardy P Jenner E Melamed RH Myers D Parker Jr DL Price 2007 The etiopathogenesis of Parkinson disease and suggestions for future research. Part I J Neuropathol Exp Neurol 66 251 257 (Pubitemid 46559017)
64. N MacInnes MM Iravani E Perry M Piggott R Perry P Jenner C Ballard 2008 Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems J Neural Transm 115 869 878
65. WR Markesbery GA Jicha H Liu FA Schmitt 2009 Lewy body pathology in normal elderly subjects J Neuropathol Exp Neurol 68 816 822
66. C Marras A Lang 2008 Invited article: changing concepts in Parkinson disease: moving beyond the decade of the brain Neurology 70 1996 2003
67. PM Mattila JO Rinne H Helenius DW Dickson M Roytta 2000 α-Synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease Acta Neuropathol 100 285 290
68. IG McKeith DW Dickson J Lowe M Emre JT O'Brien H Feldman J Cummings JE Duda C Lippa EK Perry D Aarsland H Arai CG Ballard B Boeve DJ Burn D Costa T Del Ser B Dubois D Galasko S Gauthier CG Goetz E Gomez-Tortosa G Halliday LA Hansen J Hardy T Iwatsubo RN Kalaria D Kaufer RA Kenny A Korczyn K Kosaka VM Lee A Lees I Litvan E Londos OL Lopez S Minoshima Y Mizuno JA Molina EB Mukaetova-Ladinska F Pasquier RH Perry JB Schulz JQ Trojanowski M Yamada 2005 Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium Neurology 65 1863 1872
69. GE Meredith PK Sonsalla MF Chesselet 2008 Animal models of Parkinson's disease progression Acta Neuropathol 115 385 398
70. SS Mirra A Heyman D McKeel SM Sumi BJ Crain LM Brownlee FS Vogel JP Hughes G van Belle L Berg 1991 The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease Neurology 41 479 486
71. CM Müller RA de Vos CA Maurage DR Thal M Tolnay H Braak 2005 Staging of sporadic Parkinson disease-related α-synuclein pathology: inter- and intra-rater reliability J Neuropathol Exp Neurol 64 623 628
72. G Muntane E Dalfo A Martinez I Ferrer 2008 Phosphorylation of tau and α-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related α- synucleinopathies Neuroscience 152 913 923
73. K Obi H Akiyama H Kondo Y Shimomura M Hasegawa T Iwatsubo Y Mizuno H Mochizuki 2008 Relationship of phosphorylated α-synuclein and tau accumulation to Aβ deposition in the cerebral cortex of dementia with Lewy bodies Exp Neurol 210 409 420
74. TF Outeiro PJ McLean BT Hyman 2007
75. KE Paleologou CL Kragh DM Mann SA Salem R Al-Shami D Allsop AH Hassan PH Jensen OM El-Agnaf 2009 Detection of elevated levels of soluble α-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies Brain 132 1093 1101
76. L Parkkinen H Soininen I Alafuzoff 2003 Regional distribution of α-synuclein pathology in unimpaired aging and Alzheimer disease J Neuropathol Exp Neurol 62 363 367
77. L Parkkinen T Pirttila M Tervahauta I Alafuzoff 2005 Widespread and abundant α-synuclein pathology in a neurologically unimpaired subject Neuropathology 25 304 314
78. L Parkkinen T Pirttila I Alafuzoff 2008 Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance Acta Neuropathol 115 399 407
79. T Peuralinna M Oinas T Polvikoski A Paetau R Sulkava L Niinisto H Kalimo D Hernandez J Hardy A Singleton PJ Tienari L Myllykangas 2008 Neurofibrillary tau pathology modulated by genetic variation of α-synuclein Ann Neurol 64 348 352
80. JH Power PC Blumbergs 2009 Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson's disease and dementia with Lewy bodies Acta Neuropathol 117 63 73
81. A Probst A Bloch M Tolnay 2008 New insights into the pathology of Parkinson's disease: does the peripheral autonomic system become central? Eur J Neurol 15 Suppl 1 4
82. P Riederer M Gerlach T Muller H Reichmann 2007 Relating mode of action to clinical practice: dopaminergic agents in Parkinson's disease Parkinsonism Relat Disord 13 466 479
83. Y Saito NN Ruberu M Sawabe T Arai H Kazama T Hosoi H Yamanouchi S Murayama 2004 Lewy body-related α-synucleinopathy in aging J Neuropathol Exp Neurol 63 742 749
84. MG Schlossmacher 2007
85. L Shehadeh G Mitsi N Adi N Bishopric S Papapetropoulos 2009 Expression of Lewy body protein septin 4 in postmortem brain of Parkinson's disease and control subjects Mov Disord 24 204 210
86. V Sossi R de la Fuente-Fernandez M Schulzer AR Troiano TJ Ruth AJ Stoessl 2007 Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study Ann Neurol 62 468 474
87. N Sugeno A Takeda T Hasegawa M Kobayashi A Kikuchi F Mori K Wakabayashi Y Itoyama 2008 Serine 129 phosphorylation of α-synuclein induces unfolded protein response-mediated cell death J Biol Chem 283 23179 23188
88. M Tanaka YM Kim G Lee E Junn T Iwatsubo MM Mouradian 2004 Aggresomes formed by α-synuclein and synphilin-1 are cytoprotective J Biol Chem 279 4625 4631
89. GK Tofaris MG Spillantini 2005 α-Synuclein dysfunction in Lewy body diseases Mov Disord 20 Suppl 12 S37 S44
90. H Uchikado WL Lin MW DeLucia DW Dickson 2006 Alzheimer disease with amygdala Lewy bodies: a distinct form of α-synucleinopathy J Neuropathol Exp Neurol 65 685 697
91. VN Uversky 2007 Neuropathology, biochemistry, and biophysics of α-synuclein aggregation J Neurochem 103 17 37
92. MJ Volles PT Lansbury Jr 2003 Zeroing in on the pathogenic form of α-synuclein and its mechanism of neurotoxicity in Parkinson's disease Biochemistry 42 7871 7878
93. K Wakabayashi F Mori H Takahashi 2006 Progression patterns of neuronal loss and Lewy body pathology in the substantia nigra in Parkinson's disease Parkinsonism Relat Disord 12 Suppl S92 S98
94. Y Wakisaka A Furuta Y Tanizaki Y Kiyohara M Iida T Iwaki 2003 Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study Acta Neuropathol 106 374 382 (Pubitemid 37265318)
95. EA Waxman JE Duda BI Giasson 2008 Characterization of antibodies that selectively detect α-synuclein in pathological inclusions Acta Neuropathol 116 37 46
96. D Weisman M Cho C Taylor A Adame LJ Thal LA Hansen 2007 In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution Neurology 69 356 359
97. E Wolters H Braak 2006 Parkinson's disease: premotor clinico-pathological correlations J Neural Transm Suppl 70 309 319
98. J Zaccai C Brayne I McKeith F Matthews PG Ince 2008 Patterns and stages of α-synucleinopathy: relevance in a population-based cohort Neurology 70 1042 1048